A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment

Overview of attention for article published in Frontiers in Medicine, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 201 followers.

Nasal Eos Studies A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment https://t.co/bxru2tVdtx

02 Jan 2023

Reply Repost Favourite

9-17-2022: Gifu, Japan: After methylprednisolone and colchicine had failed, the pro-oxidant, prednisone, and the antioxidant, Actemra (tocilizumab), were both called in to rescue a 64-year old man from the oxidative damage caused by VEXAS syndrome: https:

22 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.